Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · first_quarter · Q1
Department of Defense funding for research for Amyotrophic Lateral Sclerosis, contained in appropriations for Fiscal Year 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · third_quarter · Q3
Source: Senate LDA
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
ABLE Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
ABLE Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Achieving a Better Life Experience Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Achieving a Better Life Experience Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
American Middle Class Tax (AMT) Relief Act of 2007
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Superfund Polluter Pays Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
National Institutes of Health (NIH) funding within the Fiscal Year 2012 Labor-HHS-Education Appropriations Bill (S. 1599)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
Health research funding provisions, including the NIH Cures Acceleration Network of Fiscal Year 2012 Labor-HHS-Education Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · first_quarter · Q1
Health research funding provisions of H.R. 1, the Full Year Continuing Appropriations Act, 2011
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · third_quarter · Q3
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · first_quarter · Q1
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; rehabilitation research; regulatory pathway for biosimilars -HR 3590 Patient Protection and Affordable Care Act (P.L. 111-148); research and treatment of spinal muscular atrophy -HR 2149/S 1158; the Community Living Assistance Services and Supports Act -HR 1721/S 697; Competitive Bidding Repeal -HR 3790; and H1N1 distribution plans for high priority groups
Funding for amyotrophic lateral sclerosis in the Fiscal Year 2011 Department of Defense appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2009 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research, regulatory pathway for biosimilars -HR 3962 Affordable Health Care for America Act/HR 3590 Patient Protection and Affordable Care Act, research and treatment of spinal muscular atrophy -HR 2149/S 1158, the Community Living Assistance Services and Supports Act -HR 1721/S 697, Competitive Bidding Repeal -HR 3790, and H1N1 distribution plans for high priority groups
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2009 · third_quarter · Q3
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE